☰

Tenley Archer - Publications

Affiliations: 
2020- Algen Biotechnologies 
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Maynard R, Poore B, Hanaford AR, Pham K, James M, Alt J, Park Y, Slusher BS, Tamayo P, Mesirov J, Archer TC, Pomeroy S, Eberhart CG, Raabe EH. TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters. PMID 33571541 DOI: 10.1016/j.canlet.2021.02.001  0.548
2018 Archer TC, Ehrenberger T, Mundt F, Gold MP, Krug K, Mah CK, Mahoney EL, Daniel CJ, LeNail A, Ramamoorthy D, Mertins P, Mani DR, Zhang H, Gillette MA, Clauser K, et al. Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 34: 396-410.e8. PMID 30205044 DOI: 10.1016/J.Ccell.2018.08.004  0.561
2018 Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, ... ... Archer TC, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. The Lancet. Oncology. PMID 29753700 DOI: 10.1016/S1470-2045(18)30242-0  0.482
2018 Archer TC, Sengupta S, Pomeroy SL. Brain cancer genomics and epigenomics. Handbook of Clinical Neurology. 148: 785-797. PMID 29478614 DOI: 10.1016/B978-0-444-64076-5.00050-8  0.689
2017 Archer TC, Mahoney EL, Pomeroy SL. Medulloblastoma: Molecular Classification-Based Personal Therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28386677 DOI: 10.1007/S13311-017-0526-Y  0.489
2017 Boulay G, Awad ME, Riggi N, Archer TC, Iyer S, Boonseng WE, Rossetti NE, Naigles B, Rengarajan S, Volorio A, Kim JC, Mesirov JP, Tamayo P, Pomeroy SL, Aryee MJ, et al. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Cancer Discovery. PMID 28213356 DOI: 10.1158/2159-8290.Cd-16-0844  0.595
2016 Wang X, Lee RS, Alver BH, Haswell JR, Wang S, Mieczkowski J, Drier Y, Gillespie SM, Archer TC, Wu JN, Tzvetkov EP, Troisi EC, Pomeroy SL, Biegel JA, Tolstorukov MY, et al. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation. Nature Genetics. PMID 27941797 DOI: 10.1038/Ng.3746  0.565
2016 Hanaford AR, Archer TC, Price A, Kahlert UD, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dančík V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees M, Shamji AF, et al. DiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models with in silico analysis to identify novel therapeutic targets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27012813 DOI: 10.1158/1078-0432.Ccr-15-3011  0.521
2016 Hanaford A, Archer T, Price A, Kahlert U, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dančík V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees MG, Shamji A, et al. MB-103DiSCoVERing INNOVATIVE THERAPIES: COMBINING GENETICALLY ACCURATE DISEASE MODELS OF MEDULLOBLASTOMA WITH ADVANCED IN SILICO ANALYSIS TO IDENTIFY NOVEL THERAPEUTIC TARGETS Neuro-Oncology. 18: iii120.3-iii120. DOI: 10.1093/Neuonc/Now076.98  0.528
2015 Archer TC, Pomeroy SL. Defining the molecular landscape of ependymomas. Cancer Cell. 27: 613-5. PMID 25965568 DOI: 10.1016/J.Ccell.2015.04.015  0.479
2015 Hanaford A, Archer T, Tamayo P, Pomeroy S, Eberhart C, Raabe E. MB-27 * PATHWAY ANALYSIS OF A HUMAN NEURAL STEM CELL MODEL OF AGGRESSIVE MEDULLOBLASTOMA REVEALS CKD INBHIBITION AS A POTENTIAL THERAPEUTIC MODALITY Neuro-Oncology. 17: iii25-iii26. DOI: 10.1093/Neuonc/Nov061.103  0.612
2014 Archer TC, Pomeroy SL. A developmental program drives aggressive embryonal brain tumors. Nature Genetics. 46: 2-3. PMID 24370739 DOI: 10.1038/Ng.2857  0.549
2014 Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N, Kosaras B, Amani V, Pierre-Francois J, Tang Y, Nguyen B, Yu F, Schubert S, Balansay B, Mathios D, ... ... Archer TC, et al. α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. Acta Neuropathologica. 127: 593-603. PMID 24196163 DOI: 10.1007/S00401-013-1205-7  0.749
2012 Archer TC, Pomeroy SL. Medulloblastoma biology in the post-genomic era. Future Oncology (London, England). 8: 1597-604. PMID 23231521 DOI: 10.2217/Fon.12.151  0.59
2012 Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature. 488: 106-10. PMID 22820256 DOI: 10.1038/Nature11329  0.737
2012 Archer TC, Weeraratne SD, Pomeroy SL. Hedgehog-GLI pathway in medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2154-6. PMID 22508821 DOI: 10.1200/Jco.2011.41.1181  0.756
2012 Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, Kye MJ, Sengupta S, Archer T, Remke M, Bai AH, Warren P, Pfister SM, Steen JA, Pomeroy SL, Cho YJ. Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathologica. 123: 539-52. PMID 22402744 DOI: 10.1007/S00401-012-0969-5  0.712
2012 Pugh TJ, Cho Y, Archer T, Weeraratne D, Jones DTW, Jaeger N, Auclair D, Cibulskis K, Lawrence MS, Ramos AH, Shefler E, Sivachenko A, Tamayo P, Mesirov JP, Gabriel SB, et al. Abstract 4868: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations within a wide spectrum of genetic heterogeneity Cancer Research. 72: 4868-4868. DOI: 10.1158/1538-7445.Am2012-4868  0.678
2012 Weeraratne SD, Archer T, Pugh TJ, Hargreaves D, Yu F, Kautzman A, Jones DTW, Jaeger N, Tamayo P, Mesirov JP, Pfister SM, Lichter P, Crabtree G, Meyerson M, Pomeroy SL, et al. Abstract 1313: Mutually exclusive somatic mutations in WNT pathway medulloblastomas reveal a critical interaction between DDX3X and SMARCA4 Cancer Research. 72: 1313-1313. DOI: 10.1158/1538-7445.Am2012-1313  0.674
2011 Archer TC, Pomeroy SL. Posterior fossa ependymomas: a tale of two subtypes. Cancer Cell. 20: 133-4. PMID 21840477 DOI: 10.1016/J.Ccr.2011.08.003  0.556
2011 Archer TC, Jin J, Casey ES. Interaction of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis. Developmental Biology. 350: 429-40. PMID 21147085 DOI: 10.1016/J.Ydbio.2010.12.013  0.745
2009 Rogers CD, Harafuji N, Archer T, Cunningham DD, Casey ES. Xenopus Sox3 activates sox2 and geminin and indirectly represses Xvent2 expression to induce neural progenitor formation at the expense of non-neural ectodermal derivatives. Mechanisms of Development. 126: 42-55. PMID 18992330 DOI: 10.1016/J.Mod.2008.10.005  0.752
2008 Rogers CD, Archer TC, Cunningham DD, Grammer TC, Casey EM. Sox3 expression is maintained by FGF signaling and restricted to the neural plate by Vent proteins in the Xenopus embryo. Developmental Biology. 313: 307-19. PMID 18031719 DOI: 10.1016/J.Ydbio.2007.10.023  0.751
2008 Rogers C, Archer T, Casey E. Distinct mechanisms drive the induction of Sox2 and Sox3 expression in neuroectoderm International Journal of Developmental Neuroscience. 26: 874. DOI: 10.1016/J.Ijdevneu.2008.09.147  0.73
2006 Rogers C, Archer T, Grammer T, Casey ES. Regulation of SoxB1 genes in neural induction in Xenopus laevis Developmental Biology. 295: 372-373. DOI: 10.1016/J.Ydbio.2006.04.144  0.743
Show low-probability matches.